West Family Investments’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
West Family Investments's GILD Position: Q2 2026 in Review
West Family Investments reduced its Gilead Sciences (GILD) stake by 26% in Q2 2026, selling an estimated $163K and leaving 3,486 shares worth $440K. The position accounts for 0.13% of the portfolio, ranked #220.
West Family Investments first reported a position in GILD in Q2 2021 and has held it in 20 quarters since. The position peaked at $1.52M in Q4 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- West Family Investments held 3,486 shares of Gilead Sciences worth $440K as of Q2 2026.
- West Family Investments sold 1,235 Gilead Sciences shares in Q2 2026, an estimated $163K.
- Gilead Sciences made up 0.13% of West Family Investments's portfolio in Q2 2026, its #220 holding.
- West Family Investments first reported a position in Gilead Sciences in Q2 2021 and has held it in 20 quarters since.
- West Family Investments's Gilead Sciences position peaked at $1.52M in Q4 2025.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on West Family Investments's 13F filing for Q2 2026, filed 10 Aug 2026.